Clinical Guidelines
April 28, 2026
Neoadjuvant Durvalumab and Chemotherapy in Triple-Negative Breast Cancer: Long-Term Follow-Up of GeparNuevo Trial
The ASCO Post
April 28, 2026
Neoadjuvant Durvalumab and Chemotherapy in Triple-Negative Breast Cancer: Long-Term Follow-Up of GeparNuevo Trial
The ASCO Post
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
April 20, 2026
ADA seeks feedback on recommendations for using salivary tests in oral cancer detection
ADA News
Advertisement
Recommendations
Advertisement